Table 2.
Summary of Anatomic and Advanced Imaging Volumes Pre- and Post-Radiation
| Median | Pre-radiation (IQR*) N=23 | 3-Month Post-RT† (IQR) N=19 | Change (cc) (IQR) | Change (%) (IQR) |
|---|---|---|---|---|
| Enhancing tumor volume‡ (cc) | 16.9 (10.5, 33.5) | 10.4 (3.5, 15.6) | −3.0 (−9.5, 0.0) | −28 (−72, 0) |
| Hypercellular tumor volume (TV HCV , cc) | 6.0 (4.3, 10.8) | 1.1 (0.0, 8.6) | −3.5 (−5.8, −1.7) | −81 (−100, −46) |
| Hyperperfused tumor volume (TV CBV , cc) | 4.5 (1.8, 9.9) | 1.1 (0.6, 3.9) | −1.4 (−4.3, 0.0) | −63 (−87, 0) |
| Combined Union of TVHCV/TVCBV (cc) | 11.4 (6.6, 20.0) | 3.0 (1.0, 12.1) | −5.0 (−6.9, −0.4) | −60 (−88, −2) |
| Overlap of TVHCV/TVCBV (cc) | 0.5 (0.0, 1.1) | 0.0 (0.0, 0.2) | −0.2 (−0.5, 0.0) | −78 (−98, −32) |
| Non-enhancing TVHCV (cc) | 2.1 (1.5, 3.5) | 1.4 (0.0, 2.8) | −0.7 (−1.9, 0.1) | −33 (−90, 4) |
| Non-enhancing TVCBV (cc) | 1.7 (0.6, 2.8) | 0.8 (0.5, 1.5) | −0.3 (−1.3, 0.2) | −30 (−70, 30) |
| Non-enhancing Union of TVHCV/TVCBV (cc) | 3.7 (2.4, 5.9) | 2.1 (0.8, 6.0) | −1.2 (−2.9, 0.6) | −29 (−79, 8) |
| Non-enhancing Union of TVHCV/TVCBV (%) | 35.5 (24.6, 57.4) | 52.1 (27.6, 71.4) | 3.4 (−6.4, 29.4) | 16 (−20, 72) |
IQR=Interquar le range;
RT=Radia on therapy;
Excluding surgical cavity